About us

We are no typical supplement company.
We are a biotech company innovating gut relief solutions directly to you.
We're devoting our research & development to high-pain yet overlooked areas, starting with dietary fructan intolerance. And we're not stopping there: we've got a pipeline for novel enzyme technologies to address all FODMAPs (hint: polyols).

Our Story

Thanks for dropping by! My name is Anjie and 6 years ago, I was recommended to go on the low-FODMAP diet by my gastroenterologist. As many of you reading may know, the low-FODMAP diet is no walk in the park. I learned that FODMAPs are everywhere, especially in my favorite foods, which made social events — most of which involve food — incredibly stressful and a digestive landmine.

FODZYME was conceived when I asked myself one day: why isn't there a way to address the FODMAPs directly, rather than avoid a ton of delicious and nutritious foods altogether?

I rallied up a group of world-class experts in enzymology, biotechnology, medicine, and nutrition, and joined forces with my co-founder David, who has spent the last few years serving folks suffering from gut disorders with digital tools.

Together, we're on a mission to make food painless.

Anjie Liu
David Hachuel

Anjie Liu
Co-founder
Anjie studied physics at Harvard College, and started her career in consulting, which she left to focus full-time on developing FODZYME™.

David Hachuel, MPH
Co-founder
David was formerly co-founder and CEO at auggi.ai, a digital gut health coach for patients with Irritable Bowel Syndrome (IBS) which was recently acquired by Seed Health. 
David holds an MPH in Epidemiology from the Harvard School of Public Health and a Master's in Computer and Information Science from Cornell University.

Dr. Shalaka Samant
Max Resnick
Dr. Shalaka Samant
Founding Scientist, R&D
Dr. Samant is an expert in microbial biotechnology and enzyme development. Dr. Samant obtained her Ph.D. in pharmaceutical biotechnology from the University of Illinois – Chicago and completed postdoctoral research at Yale University and the University of Texas – Houston.
Max Resnick
Content Writer, Community Manager

Max began his FODZYME journey as a customer. With a background in science-communication and customer support, Max found his place on the team. A Bachelor’s of Science degree from UMass Amherst in Sustainable Food and Farming helps Max clearly write and create palatable content to help educate customers on the science of enzymes and the usage of FODZYME. During the buildup of his digestive-health journey, Max learned the importance of a sustainable diet. This extended into his formal education, where he learned skills and concepts to maintain healthy-and-resilient food systems. A large portion of the Sustainable Food and Farming degree focused on soil microbiota, which perfectly compliments Max’s lived-experience and self-education on the human microbiome.

Dr. Alex Ivliev, Biostatistician

Dr. Thomas Wallach, MD

Dr. Alexander Ivliev
Advisor, Bioinformatics and Computational Biology
Dr. Alex Ivliev is an expert in bioinformatics. For 10 years, he has been helping dozens of pharmaceutical and biotech companies develop novel medications for a broad range of diseases through rigorous data analysis in experimental research and clinical trials. He has worked as a Senior and Principal Scientist at Thomson Reuters and as the Director of Bioinformatics at Clarivate Analytics in Boston. He holds a Ph.D. in bioinformatics and computational biology from the Moscow State University, Moscow. 
Dr. Thomas Wallach, MD
Advisor,  Gastroenterology and Clinical Research
Dr. Thomas Wallach, MD is a translational scientist and pediatric gastroenterologist, with a focus on intestinal epithelial biology and diseases of gut brain interaction such as IBS. He completed his medical education at the Medical College of Wisconsin, his residency training at Columbia University, and a research and clinical fellowship in pediatric gastroenterology at the University of California, San Francisco. During his time at UCSF Dr. Wallach completed several mechanistic studies focused on review of the impact of generally regarded as safe (GRAS) substances on intestinal epithelial function. Clinically, he has completed focused training in gastrointestinal pain management, including the study of underlying mechanisms, current best practices in management, and training in acceptance and commitment therapeutic modalities. He is currently an Assistant Professor of Pediatrics at SUNY Downstate Health Sciences University in Brooklyn, NY.

Dr. Alan Jiang

Dr. Alan Jiang 
Advisor, Formulation and Regulatory

Dr. Jiang was formerly the Director of Nutrition Lab at Johns Hopkins University and has extensive experience in nutraceutical formulation. Dr. Jiang was trained as a gastroenterologist and holds a Ph.D. in Nutrition from University of Minnesota – Twin Cities.